Nelarabine - Moligand™, ≥98% , DNA inhibitor, CAS No.121032-29-9, DNA inhibitor

CAS: 121032-29-9 Cat. No.: N127709 Fórmula: C11H15N5O5 Peso molecular: 297.27 Número EC: 642-916-9
Disponible para pedir
CALIDAD & PUREZA Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%
Synonyms
506U78|Arranon|Nelzarabine|9beta-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine|9-(β-D-Arabinofuranosyl)-6-methoxy-9H-purin-2-amine|(2R,3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
Storage
Protected from light,Store at -20°C,Argon charged
Shipped In
Ice chest + Ice pads
★
Talla
Alemania (EU)
USA*
Precio
Cantidad
50mg
N127709-50mg
—
3 Disponible

78,88€

118,79€
Guardar 39,92 € (33.60%)
250mg
N127709-250mg
—
3 Disponible

169,12€

254,16€
Guardar 85,04 € (33.46%)
1g
N127709-1g
—
2 Disponible

416,43€

624,69€
Guardar 208,26 € (33.34%)
Enter a quantity for the sizes you want to add.

Descripción general

Nelarabine is a purine nucleoside analog and DNA synthesis inhibitor with IC50 from 0.067-2.15 μM in tumor cells.

Nelarabine (arranon, 506U78) is a purine nucleotide analog, which is an inhibitor of DNA synthesis, with an IC50 of 0.067-2.15 for tumor cells μ M. It can act on T cells and acute lymphoblastic leukemia.

Especificaciones

Sinónimos
506U78 | Arranon | Nelzarabine | 9beta-D-Arabinofuranosyl-6-methoxy-9H-purin-2-amine | 9-(β-D-Arabinofuranosyl)-6-methoxy-9H-purin-2-amine | (2R,3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
Especificaciones y pureza
Moligand™, ≥98%
Mecanismos bioquímicos y fisiológicos
Nucleoside analog. Metabolized by adenosine deaminase to active metabolite, arabinofuranosylguanine (ara-G). Inhibits DNA synthesis and induces apoptosis. Inhibits growth of human T cell lymphoblastic leukemia cellsin vitroandin vivo.
Condiciones de almacenamiento de almacenamiento
Protected from light,Store at -20°C,Argon charged
Enviado en
Ice chest + Ice pads
Este producto requiere envío en cadena de frío. Los servicios terrestres y otros servicios económicos no están disponibles.
Grado
Moligand™
Tipo de acción
INHIBITOR
Mecanismo de acción
DNA inhibitor
Pureza
≥98%
Propiedades del producto
ALogP
-0.7
Nombres e identificadores
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/504762289
SMILES
COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N
IUPAC Name
(2R,3S,4S,5R)-2-(2-amino-6-methoxypurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
InChIKey
IXOXBSCIXZEQEQ-UHTZMRCNSA-N
InChI
1S/C11H15N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7+,10-/m1/s1
Isómeros SMILES
COC1=NC(=NC2=C1N=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)N
Peso molecular
297.27
Reaxys
841479
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=841479&ln=

Datos avanzados

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassNucleosides, nucleotides, and analogues
ClasePurine nucleosides
SubclassNot available
Intermediate Tree Nodes Not available
Direct ParentPurine nucleosides
Alternative Parents Glycosylamines  Pentoses  Hypoxanthines  Aminopyrimidines and derivatives  Alkyl aryl ethers  N-substituted imidazoles  Tetrahydrofurans  Heteroaromatic compounds  Secondary alcohols  Oxacyclic compounds  Azacyclic compounds  Primary amines  Primary alcohols  Organopnictogen compounds  Hydrocarbon derivatives  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Purine nucleoside - Glycosyl compound - N-glycosyl compound - Hypoxanthine - Pentose monosaccharide - Purine - Imidazopyrimidine - Aminopyrimidine - Alkyl aryl ether - Pyrimidine - Monosaccharide - N-substituted imidazole - Heteroaromatic compound - Azole - Tetrahydrofuran - Imidazole - Secondary alcohol - Oxacycle - Azacycle - Organoheterocyclic compound - Ether - Organopnictogen compound - Alcohol - Organic oxygen compound - Organic nitrogen compound - Hydrocarbon derivative - Amine - Primary amine - Primary alcohol - Organooxygen compound - Organonitrogen compound - Aromatic heteropolycyclic compound
DescripciónThis compound belongs to the class of organic compounds known as purine nucleosides. These are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety.
External Descriptors purine nucleoside - monosaccharide derivative - beta-D-arabinoside
Estructura 3D
Modelo de Estructura Química Interactiva





Objetivos asociados (humanos)
Homo sapiens (32628 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-HSB-2 (188 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
THP-1 (11052 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Jurkat (10389 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCC2 Tchem Canalicular multispecific organic anion transporter 1 (1191 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCB11 Tchem Bile salt export pump (2311 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCC3 Tbio Canalicular multispecific organic anion transporter 2 (718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TDP1 Tchem Tyrosyl-DNA phosphodiesterase 1 (345557 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABCC4 Tchem Multidrug resistance-associated protein 4 (785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Objetivos asociados (no humanos)
Hdac6 Histone deacetylase 6 (222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mecanismos de acción
Certificados (CoA, COO, BSE/TSE y tabla de análisis)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

4 results found

Lot NumberCertificate TypeFechaArticulo
B2316265B2316265Certificate of AnalysisAug 13, 2026 N127709
B2316263B2316263Certificate of AnalysisAug 13, 2026 N127709
B2316255B2316255Certificate of AnalysisAug 13, 2026 N127709
C2512086C2512086Certificate of AnalysisMar 19, 2025 N127709
Propiedades químicas y físicas
SolubilidadSolvent:DMSO, Max Conc. mg/mL: 29.73, Max Conc. mM: 100; Solvent:water, Max Conc. mg/mL: 2.97, Max Conc. mM: 10 with gentle warming
Sensibilidadlight sensitive;Moisture sensitive;heat sensitive
Peso molecular297.27
XLogP3-0.700
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count9
Rotatable Bond Count3
Exact Mass297.107 Da
Monoisotopic Mass297.107 Da
Topological Polar Surface Area149.000 Ų
Heavy Atom Count21
Formal Charge0
Complexity377.000
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Seguridad y peligros (GHS)
Pictogramas
GHS07,   GHS08
Señal
Danger
Indicaciones de peligro

H302:Harmful if swallowed

H315:Causes skin irritation

H319:Causes serious eye irritation

H335:May cause respiratory irritation

H341:Suspected of causing genetic defects

H351:Suspected of causing cancer

H360:May damage fertility or the unborn child

H361:Suspected of damaging fertility or the unborn child

H361fd:Suspected of damaging fertility; Suspected of damaging the unborn child

H372:Causes damage to organs through prolonged or repeated exposure

H413:May cause long lasting harmful effects to aquatic life

Precauciones

P260:Do not breathe dust/fume/gas/mist/vapors/spray.

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P264:Wash hands [and …] thoroughly after handling.

P270:Do not eat, drink or smoke when using this product.

P271:Use only outdoors or in a well-ventilated area.

P273:Avoid release to the environment.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P281:Use personal protective equipment as required.

P321:Specific treatment (see ... on this label).

P330:Rinse mouth.

P302+P352:IF ON SKIN: wash with plenty of water.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P362+P364:Take off contaminated clothing and wash it before reuse.

P405:Store locked up.

P403+P233:Store in a well-ventilated place. Keep container tightly closed.

P501:Dispose of contents/container to an approved waste disposal plant.

P203:Obtain, read and follow all safety instructions before use.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P301+P317:IF SWALLOWED: Get medical help.

P318:if exposed or concerned, get medical advice.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

P319:Get medical help if you feel unwell.

Reaxys
841479
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=841479&ln=
Preguntas frecuentes y artículos
Citations of This Product
Calculadoras de soluciones
Reseñas

Reseñas de cliente

Application Protocols

No item-specific, validated protocols are provided in the Product Data. The following are general, non-clinical research procedures to facilitate laboratory use; optimize for your system.

  • Preparation of stock solutions

    • DMSO stock: Weigh nelarabine quickly under low light. Dissolve to 10–50 mM in anhydrous DMSO. Vortex and, if needed, sonicate briefly. Aliquot into amber microtubes, argon backfill, and store at −20 °C. Avoid >3 freeze–thaw cycles.
    • Aqueous stock: Dissolve in sterile water or PBS at 1–10 mM. Filter through 0.22 μm. Use fresh or aliquot and freeze at −20 °C protected from light.
  • Cell-based dosing (exploratory framework)

    • Thaw an aliquot on ice; dilute into pre-warmed medium to achieve final solvent ≤0.1–0.5% DMSO. Prepare a concentration range (e.g., 0.01–100 μM) for titration studies. Include vehicle controls.
    • Incubate per assay design (e.g., 24–72 h) and quantify readouts such as proliferation (resazurin), DNA synthesis (EdU), or cell cycle by flow cytometry.
  • Enzyme assays (ADA conversion)

    • Buffer: 50 mM phosphate, pH 7.4; 25 °C. Initiate with ADA enzyme and monitor formation of ara‑G by LC–MS at defined timepoints.
    • Quench: add equal volume of cold MeOH (protein precipitation), centrifuge, analyze supernatant by LC–MS.
  • Analytical QC

    • HPLC: C18, water/MeOH (0.1% formic acid), gradient 5–40% MeOH over 10 min; detect at 260–270 nm. Confirm identity by MS (m/z ~298 [M+H]+, literature context).

These examples are provided for research planning; adjust conditions based on pilot experiments and institutional SOPs.

Biological Roles

The following describes biochemical roles of nelarabine and its metabolites for research context only (no medical/clinical claims).

  • Metabolic activation (literature/general)

    • Nelarabine is converted by adenosine deaminase to arabinosylguanine (ara-G). Ara-G is then phosphorylated by deoxyguanosine kinase and deoxycytidine kinase to the triphosphate (ara‑GTP).
    • Ara‑GTP can incorporate into nascent DNA in dividing cells, perturbing DNA synthesis and repair processes.
  • Transport and disposition (literature/general)

    • Cellular uptake primarily via equilibrative nucleoside transporters ENT1/ENT2; intracellular phosphorylation traps the metabolite.
    • Catabolism may involve nucleoside phosphorylases and deamination pathways; efflux via nucleoside transporters can be studied.
  • Cellular readouts (research use)

    • Inhibition of DNA polymerization, S-phase perturbation, and DNA damage signaling can be quantified by EdU/BrdU assays, γH2AX immunostaining, and cell-cycle cytometry.
    • Enzyme kinetics of ADA, dCK, and dGK toward nelarabine/ara-G can be determined using coupled spectrophotometric or LC–MS assays.
  • Selectivity considerations (literature/general)

    • Lymphoid-lineage cells are often used in research models for nucleoside analog metabolism due to kinase/transporter expression profiles; however, actual sensitivity varies with enzyme/transporter levels.

These roles provide mechanistic handles for experimental design in nucleoside metabolism, transporter biology, and DNA synthesis studies.

Buffer Applications

Nelarabine is not a buffering agent; however, buffer choice is important for its handling in biochemical and cell-based experiments.

  • Recommended buffer systems (general guidance)

    • PBS (pH 7.2–7.4) or HEPES (pH 7.2–7.6) for cell culture dosing solutions; maintain isotonicity.
    • Tris or phosphate buffers (pH 7.0–7.8) for enzyme assays involving ADA, dCK, or dGK; include Mg2+ only if required by the enzyme system.
  • Practical preparation

    • Prepare a concentrated nelarabine stock in water or DMSO; dilute into the working buffer to the desired final concentration, keeping DMSO ≤0.1–0.5% v/v for live-cell assays.
    • Filter sterilize (0.22 µm) if sterility is required; use amber tubes to protect from light.
    • Avoid extremes of pH (<6 or >8) to minimize glycosidic hydrolysis.
  • Stability tips

    • Prepare fresh working solutions daily or store aliquots at −20 °C protected from light; avoid repeated freeze–thaw cycles.

For specific buffer recipes and compatibility with your biological system, validate empirically, as degradation and adsorption can be system-dependent.

Green Alternatives

As a solid research compound rather than a process solvent, “green alternatives” focus on media and workflows used with the material.

  • Preferred media

    • Use water or buffered aqueous solutions whenever compatible with the experiment; these are inherently greener than organic solvents.
    • If an organic cosolvent is required, minimize DMSO content and consider ethanol as a more benign alternative for some analytical tasks.
  • Comparison (general guidance)

    | Aspect | Aqueous buffer | Ethanol | DMSO | |---|---|---|---| | Environmental profile | Excellent (green) | Good | Moderate (problematic in effluent) | | Solubilizing power | Moderate–High (for nucleosides) | Moderate | High | | Bioassay compatibility | High | Medium (can perturb membranes) | Medium (limit ≤0.1–0.5% v/v) | | Stability impact | Good at neutral pH/cold | Similar to water | Good, but hygroscopic |

  • Operational tips

    • Adopt small-volume, high-concentration master stocks to reduce solvent usage.
    • Use amber vials and cold chains to minimize degradation and repeat syntheses/purchases.
    • Favor LC–MS-compatible, volatile mobile phases (water + MeOH/ACN with low-buffer) for analytics to reduce waste in preparative steps.

Note: No greener “substitute molecule” is appropriate; choice centers on greener solvents and minimal-waste handling.

Pharmaceutical Uses

This product is supplied strictly for research use only. No medical or clinical use is intended or permitted.

  • Research and analytical contexts (non-clinical)

    • Reference standard in developing and qualifying LC–UV/LC–MS methods for nucleoside analogs.
    • Stability-indicating method development (forced degradation under acid/base, oxidative, and photolytic conditions) to map impurity pathways of purine arabinosides.
    • In vitro formulation screening for solubility and compatibility (e.g., co-solvent percentage, pH adjustment, lyophilization feasibility) to support pre-formulation research.
  • Excipient status and pharmacopeia

    • Nelarabine is an active small molecule, not an excipient. No pharmacopeial excipient monograph applies. Any pharmacopeial references, if needed, should be consulted only for analytical methodology examples (general chapters) rather than specifications.
  • Handling in pharmaceutical R&D labs

    • Use analytical-grade solvents and validated reference materials when constructing calibration curves.
    • Document chain-of-custody and storage conditions to support data integrity in regulated environments; qualify this material as a secondary reference if used alongside primary standards.

Always segregate research-grade materials from clinical supply chains and follow institutional governance for controlled compounds.

Physical Properties

Item-specific specifications are not provided in the Product Data.

  • Item-specific values

    • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
  • Literature/general reference values (for context; not product specifications)

    • Molecular formula (literature): C11H15N5O5
    • Molecular weight (literature): ~297.27 g/mol
    • Physical state: typically a crystalline solid for nucleoside analogs (literature/general)
    • Solubility: generally soluble in polar media such as water and DMSO; limited in nonpolar solvents (literature/general for nucleoside analogs). Practical lab stocks are often prepared at 10–50 mM in DMSO or water, depending on assay requirements.
    • LogP: expected very low/negative due to multiple hydroxyls (literature/general trend for arabinosyl nucleosides).
    • pKa: purine N1 and exocyclic amine exhibit weak basicity; overall neutral at physiological pH (literature/general for guanine analogs).
  • Optical data (if used for assay QC)

    • UV absorption: purine chromophore typically absorbs at ~260–280 nm (literature/general); exact λmax may shift with substitution and solvent.

For authoritative specifications (melting point, water content, UV cutoff, metals, residual solvents), consult the product’s CoA/Spec Sheet; do not infer from literature values for QC release.

Quality and Grades
  • Supplied grade (Product Data)

    • Moligand™ grade. Specific assay parameters (purity method/percent, residual solvents, water, metals, UV profile) are not listed for this item; refer to the CoA/Spec Sheet.
  • Context for Moligand™ (general description)

    • Positioned for research and discovery workflows where chemical identity and consistency are critical for screening, biochemical assays, or probe development. While “Moligand™” is a proprietary designation, users should rely on the batch CoA for concrete release tests (identity by NMR/HRMS/LC–MS, chromatographic purity, etc.).
  • What to check on receipt

    • Identity: verify by LC–MS and 1H NMR against literature or in-house reference spectra for nelarabine.
    • Purity: confirm by HPLC/UPLC with diode-array detection at ~260–280 nm (purine absorbance). Orthogonal assessment by 13C NMR is recommended for nucleosides due to sugar-ring resonances.
    • Water content: Karl Fischer as needed (nucleosides are often hygroscopic to a degree).
    • Stability: verify stability under your assay storage (frozen aliquots; light protection) by short-term isochronous testing.
  • Stabilizers/ additives

    • None specified for this item; refer to CoA/Spec Sheet.
  • Compliance and traceability

    • Research use only. Not intended for human or veterinary use. For regulated workflows (GLP/GMP), qualify the material internally and maintain chain-of-custody documentation.
Reaction and Applications

This compound is primarily used as a nucleoside analog standard and research probe in chemical biology and nucleoside chemistry.

  • Research applications (general, non-clinical)

    • Biochemical pathway studies: conversion to arabinosylguanine (ara-G) and subsequent phosphorylation to ara-GTP by cellular kinases can be profiled in lysates or cell culture using LC–MS metabolite tracing.
    • Transporter studies: uptake via equilibrative nucleoside transporters (ENT1/ENT2) can be quantified by radiometric or LC–MS methods using nelarabine or its metabolite as substrates.
    • Enzymology: assessment of adenosine deaminase–mediated conversion of nelarabine to ara-G; kinase specificity of dGK/dCK toward ara-G.
    • Analytical reference: HPLC/UPLC method development at ~260–280 nm for nucleoside separation; use as a retention marker or spike-recovery standard.
  • Chemical applications (nucleoside chemistry)

    • Protection/deprotection sequences on the arabinose (e.g., 5′-O-DMTr, 2′/3′-O-TBS) to enable selective derivatization.
    • N9-glycosidic stability studies under acid/base; synthesis of analog libraries via modifications on the purine 6-position (after demethoxylation or via SNAr strategies).
  • Practical tips

    • Maintain neutral pH and low temperature when handling in water.
    • For derivatization, rigorously dry solvents and use molecular sieves; residual water causes anomerization/hydrolysis.
    • Monitor reactions/assays by LC–MS with soft ionization (ESI+) and multiple wavelengths (254/270 nm) for robust tracking.
Reaction Conditions

General conditions below reflect literature practices for nucleoside manipulation; they are not product specifications.

  • Protection/deprotection

    • 5′-O-DMTr installation: DMTrCl, pyridine or DCM with catalytic DMAP, 0–25 °C, 1–6 h; workup by aqueous quench and silica gel chromatography (monitor at 498/254 nm).
    • 2′,3′-O-acetonide: acetone, catalytic acid (e.g., CSA), 0–25 °C; reversible under mild acid.
    • Silyl protections (TBS/TBDMS): imidazole, TBSCl in DMF, 0–25 °C, 2–16 h; remove with TBAF in THF.
  • Phosphorylation (5′-OH)

    • POCl3 in trimethyl phosphate at −20 to 0 °C to form 5′‑monophosphate, followed by pyrophosphate coupling or enzymatic steps to higher phosphates; typical isolated yields vary widely (30–70%) due to hydrolysis.
    • Phosphoramidite chemistry: 2‑cyanoethyl-N,N‑diisopropylchlorophosphoramidite reagents, DIPEA, 0–25 °C; oxidation with mCPBA/I2–water.
  • Base-ring modifications

    • Displacement or modification at C6 may require activation; SNAr conditions typically involve polar aprotic solvents (DMF/DMSO), nucleophiles, and elevated temperatures (50–120 °C) with careful protection of sugar hydroxyls.
  • Analytics and monitoring

    • LC–MS (ESI+) with water/MeOH (0.1% formic acid or ammonium formate) for tracking; UV at 254–270 nm for purine chromophore.
    • NMR in DMSO‑d6 or D2O (exchangeable protons may broaden/suppress signals); verify β-anomer via J1′,2′.
  • Stability

    • Maintain neutral pH, protect from light, and limit heat exposure to preserve the glycosidic bond during reactions and workups.
Safety and Handling
  • Classification (item-specific)

    • Signal word, H-statements, GHS class, pictograms: Not specified for this item; refer to the SDS.
  • General laboratory precautions (good practice for nucleoside analogs; not a substitute for SDS)

    • Engineering controls: handle in a chemical fume hood or biosafety cabinet when weighing/aliquoting powders to minimize inhalation and cross-contamination.
    • PPE: lab coat, nitrile gloves (double-gloving for extended handling), and safety glasses or splash goggles.
    • Avoid: generating dust/aerosols; contact with skin, eyes, and clothing; ingestion and inhalation. Wash thoroughly after handling.
    • Incompatibilities: strong oxidizers and strong acids/bases can degrade the glycosidic linkage or the purine ring (general nucleoside chemistry). Avoid prolonged exposure to moisture and light.
    • Special risks: light- and moisture-sensitive degradation possible; follow storage guidance strictly. Avoid repeated freeze–thaw of solutions to prevent hydrolytic decomposition.
  • First aid (overview; defer to SDS)

    • Skin/eye contact: rinse with water for at least 15 minutes; remove contaminated clothing.
    • Inhalation: move to fresh air; seek medical attention if symptoms persist.
    • Ingestion: rinse mouth; seek medical attention. Do not induce vomiting unless advised by medical personnel.
  • Waste disposal

    • Collect residues/solutions as halogen-free organic or aqueous pharmaceutical research waste per institutional and local regulations. Deactivate/neutralize only if validated by your EHS group.

Always consult the product-specific SDS for authoritative hazard classification and response instructions.

Solvent Selection

Nelarabine is a highly polar, hydrogen-bonding nucleoside analog; solvent choice should prioritize solubility, chemical stability, and assay compatibility.

  • Polarity and miscibility (general behavior)

    • Prefer polar protic (water, buffered saline) or polar aprotic (DMSO) solvents.
    • Poorly soluble in nonpolar solvents (hexanes, toluene). Alcohols (MeOH, EtOH) can dissolve at modest concentrations but may compete in hydrogen bonding.
  • Practical stock solutions

    • DMSO: robust solubilizer; prepare 10–100 mM master stocks, then dilute into aqueous media. Filter-sterilize if needed (0.22 μm PTFE/PES). Minimize final DMSO in biological assays (≤0.1–0.5% v/v).
    • Water/Buffer: nelarabine often dissolves directly in water or physiological buffers (PBS, HEPES); warm gently (≤37 °C) and vortex/sonicate to aid dissolution. Adjust pH only if necessary; avoid strong base/acid.
  • Stability considerations

    • Aqueous hydrolysis of the glycosidic bond is promoted by extremes of pH and elevated temperature; keep neutral pH and cold storage.
    • Light can accelerate degradation; protect with amber vials and foil during preparation and storage.
  • Choosing between solvents

    • For biochemical assays: use aqueous buffers; introduce minimal DMSO as a cosolvent only if needed.
    • For chemical transformations or derivatizations: use polar aprotic media (DMF, DMSO) with careful control of moisture; consider protecting groups to improve solubility in organic phases.
  • Small comparison (general)

    • Water: green, biocompatible; limited long-term stability unless frozen/aliquoted.
    • DMSO: excellent solubility; potential biological effects; hygroscopic.
    • MeOH/EtOH: intermediate option for analytics; volatility aids removal but may affect bioassays.
Storage and Reconstitution
  • Storage (item-specific, Product Data)

    • Store at −20 °C.
    • Protect from light.
    • Argon charged (maintain an inert atmosphere in headspace where practicable).
    • Shipped with ice packs in an ice chest to preserve the cold chain.
  • General stability guidance

    • Keep container tightly closed and desiccated. Nucleoside analogs can absorb moisture; humidity control improves shelf life.
    • Minimize temperature cycling; withdraw material quickly and return to −20 °C.
  • Reconstitution

    • Use anhydrous DMSO or sterile water as primary solvents. Bring solvent to room temperature, then dissolve the weighed solid with gentle mixing. Avoid strong acids/bases.
    • For sterile applications, filter reconstituted solutions through a 0.22 μm membrane into sterile, amber vials.
  • Aliquoting and freeze–thaw

    • Prepare single-use aliquots to avoid repeated freeze–thaw. For DMSO stocks, consider small amber screw-cap vials or crimped autosampler vials with inert gas headspace.
  • In-use handling

    • Keep solutions on ice and protected from light during experiments. Discard solutions that show precipitation, discoloration, or unexpected LC–MS/HPLC profiles.

For definitive shelf-life and retest information, consult the lot-specific CoA/Spec Sheet and the SDS. Research use only.

Structure and Identity

Nelarabine is a purine nucleoside analog supplied for research use.

  • Item-specific identifiers (Product Data)

    • SKU: N127709
    • CAS: 121032-29-9
    • Category: Life Science reagents (研究/实验用)
    • Grade/Purity: Moligand™ (see Quality & Grades)
    • InChIKey (as provided): 153118 (note: truncated/incomplete in Product Data)
  • Literature structural identity (for scientific context; not item-specific specifications)

    • Common name: Nelarabine; prodrug of arabinosylguanine (ara-G)
    • Molecular formula (literature): C11H15N5O5
    • Molecular weight (literature): ~297.27 g/mol
    • SMILES (literature): OC[C@@H]1OC@HC@@H[C@H]1O
    • InChIKey (literature): SVISWZPOKNIWBL-NXQOOQHPSA-N
  • Structural features (general description)

    • Core: 6-methoxy-substituted purine ring bearing an exocyclic 2-amino group (guanine analog) attached N9 to a β-D-arabinofuranose.
    • Sugar: β-D-arabinofuranose with three secondary alcohols and one primary alcohol (at C5′), all stereodefined.
    • Functional groups: heteroaromatic purine, primary amine (C2), methoxy at C6, multiple alcohols on the pentose.
    • Stereochemistry: Four stereocenters on the arabinose (β-configuration at the anomeric position); literature SMILES encodes absolute configuration.

Note: Where literature identifiers differ from Product Data, defer to the item’s CoA/Spec Sheet for definitive identity used for release.

Synthetic Utility

While commonly employed as a research probe/standard, nelarabine also serves as a starting point for nucleoside chemistry.

  • Functional handles

    • Purine heterocycle: substituent at C6 (methoxy) enables downstream transformations (e.g., demethoxylation to guanine analogs or nucleophilic aromatic substitution with suitable activation).
    • Sugar hydroxyls: 5′-primary and 2′/3′-secondary alcohols enable selective protection and elaboration to phosphates, carbamates, or carbonate prodrugs.
  • Typical transformations (literature/general)

    • Protection strategies: 5′-O-DMTr for solid-phase applications; 2′,3′-O-acetonide or silyl protections (TBS/TBDMS) to control reactivity.
    • Phosphorylation: chemical introduction of monophosphate at 5′-OH (POCl3/trimethyl phosphate or phosphoramidite chemistry) en route to di- and triphosphates via kinase catalysis.
    • Glycosidic stability studies: selective hydrolysis or transglycosylation under Lewis/Brønsted acid catalysis.
  • Retrosynthetic value

    • Nelarabine can be traced back to protected arabinose donors and 6-methoxy substituted purine bases; modern routes often employ Vorbrüggen-type glycosylation (silylated base + activated sugar) followed by deprotection.
  • Analytical control

    • Monitor anomeric purity (β vs α) and sugar configuration by 1H NMR (H‑1′ coupling constants), and confirm substitution on C6 by 13C shifts and HMBC.

These features make nelarabine a versatile scaffold for preparing analog libraries and studying structure–activity relationships within purine arabinosides.

Target Specificity

Not applicable. This product is a small-molecule nucleoside analog, not an antibody, protein, or targeted biological reagent. No antigen/epitope, clone, or species reactivity information applies. For mechanism-related context, see Biological Roles.

Preguntas frecuentes

What is the purity of this product?
This product is supplied at ≥98% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at ?20 °C, protected from light, under argon. It is supplied under an argon blanket; reseal under inert gas after each use.
How is this product shipped?
This product ships in an insulated container with ice pads. Unpack on arrival and transfer it to the storage condition stated above.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 121032-29-9, the molecular formula is C11H15N5O5, and the molecular weight is 297.27 g/mol. InChIKey IXOXBSCIXZEQEQ-UHTZMRCNSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

¿Quieres que te enviemos un mensaje cuando tengamos descuentos disponibles?

Recordármelo más tarde

¡Gracias! Por favor, revisa tu bandeja de entrada de correo electrónico para confirmar.

¡Vaya! Las notificaciones están desactivadas.